Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

CompletedOBSERVATIONAL
Enrollment

689

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2016

Conditions
Lung Cancer
Interventions
GENETIC

comparative genomic hybridization

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

protein expression analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

matrix-assisted laser desorption/ionization time of flight mass spectrometry

OTHER

medical chart review

PROCEDURE

diagnostic bronchoscopy

Trial Locations (4)

37064

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville

Vanderbilt-Ingram Cancer Center at Franklin, Nashville

37212

Veterans Affairs Medical Center - Nashville, Nashville

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT00899028 - Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants | Biotech Hunter | Biotech Hunter